Adjuvant Immunization of HLA-A2–Positive Melanoma Patients With a Modified gp100 Peptide Induces Peptide-Specific CD8+ T-Cell Responses Purpose: Successful therapeutic interventions to prevent disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback